BRISTOL MYERS SQUIBB
Live / Registered — Registered (as of 12 Apr 2022)
What this means for you
Registered since 12 Apr 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88703275
- Registration number
- 6702019
- Mark type
- Design + words
- Filed
- 22 Nov 2019
- Published for opposition
- 08 Dec 2020
- Registered
- 12 Apr 2022
- Attorney of record
- Marilyn F. Kelly
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for the treatment and prevention of cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, arthritis; Pharmaceutical preparations for human use, namely, antibiotics, immunosuppressants, immunotherapies for the treatment of cancer; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, including T Cell therapy
- Class 042 — Scientific and technological services: Pharmaceutical research and development services
Owner
- Bristol-Myers Squibb Company, Princeton, NJ, US
- Bristol-Myers Squibb Company, New York, NY, US
- Bristol-Myers Squibb Company, New York, NY, US
Prior registrations
Prosecution history
- 02 Aug 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 02 Aug 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 02 Aug 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 02 Aug 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 02 Aug 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 12 Apr 2022 — REGISTERED-PRINCIPAL REGISTER
- 05 Mar 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 04 Mar 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 19 Feb 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Feb 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 02 Feb 2022 — USE AMENDMENT FILED
- 18 Feb 2022 — SOU EXTENSION 2 GRANTED
- 02 Feb 2022 — SOU EXTENSION 2 FILED
- 15 Feb 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 09 Feb 2022 — ITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST